Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$327,444
-$47,822 QoQ
Shares Held
273
-33.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4,086
of 4,605 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dixon Mitchell Investment Counsel Inc. holds $10,901,778 across 3 Drug Manufacturers - General names. LLY ranks #2 (3.0% of the industry book) .
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $327,444 | 273 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $375,266 | 408 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $438,469 | 408 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $7,433 | 9 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,948 | 9 | Shares | Sole | 2025-01-15 | |
| No filing history on record for this holder in this stock. | ||||||